Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 48 articles: HTML format

Single Articles

September 2022
1. WU VC, Peng KY, Hu YH, Chang CC, et al
   Circulating Plasma Concentrations of ACE2 in Primary Aldosteronism and Cardiovascular Outcomes.
   J Clin Endocrinol Metab. 2022 Sep 19. pii: 6705062. doi: 10.1210.
   PubMed     Abstract available
   
   
   
2. NESTEL P, Loh WJ, Ward NC, Watts GF, et al
   New Horizons: Revival of Lipoprotein (a) as a risk factor for cardiovascular disease.
   J Clin Endocrinol Metab. 2022 Sep 15. pii: 6701631. doi: 10.1210.
   PubMed     Abstract available
   
   
   
3. 
   Correction to: "Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes".
   J Clin Endocrinol Metab. 2022 Sep 14. pii: 6698734. doi: 10.1210.
   PubMed    
   
   
   
4. LI Y, Gao R, Zhao B, Zhang Y, et al
   Low serum bicarbonate levels increased the risk of all-cause, cardiovascular and cancer Mortality in type 2 diabetes.
   J Clin Endocrinol Metab. 2022 Sep 6. pii: 6692819. doi: 10.1210.
   PubMed     Abstract available
   
   
   
5. WEI H, Zhao M, Wu J, Li C, et al
   Association of Systemic Trimethyllysine with Heart Failure with Preserved Ejection Fraction and Cardiovascular Events.
   J Clin Endocrinol Metab. 2022 Sep 5. pii: 6691858. doi: 10.1210.
   PubMed     Abstract available
   
   
   August 2022
6. DONG Y, Chen Z, Gong Y, Han Y, et al
   The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis (jc.2022-01089).
   J Clin Endocrinol Metab. 2022 Aug 16. pii: 6666536. doi: 10.1210.
   PubMed     Abstract available
   
   
   
7. DONG Y, Chen Z, Gong Y, Han Y, et al
   The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis.
   J Clin Endocrinol Metab. 2022 Aug 15. pii: 6666536. doi: 10.1210.
   PubMed     Abstract available
   
   
   June 2022
8. HOU T, Li M, Lin H, Zhao Z, et al
   The causal effect of systolic blood pressure lowering on vascular outcomes in diabetes: a Mendelian randomization study.
   J Clin Endocrinol Metab. 2022 Jun 15. pii: 6608757. doi: 10.1210.
   PubMed     Abstract available
   
   
   May 2022
9. CHOI HR, Chang Y, Kim Y, Cho Y, et al
   Ideal cardiovascular health metrics and risk of incident early-onset vasomotor symptoms among premenopausal women.
   J Clin Endocrinol Metab. 2022 May 21. pii: 6590294. doi: 10.1210.
   PubMed     Abstract available
   
   
   
10. LETO G, Tartaglione L, Rotondi S, Pasquali M, et al
    Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease.
    J Clin Endocrinol Metab. 2022 May 20. pii: 6590071. doi: 10.1210.
    PubMed     Abstract available
    
    
    April 2022
11. CUKIERMAN-YAFFE T, Gerstein HC, Basile J, Bethel MA, et al
    Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
    J Clin Endocrinol Metab. 2022 Apr 21. pii: 6569991. doi: 10.1210.
    PubMed     Abstract available
    
    
    
12. SUZUKI Y, Kaneko H, Okada A, Matsuoka S, et al
    Prediabetes in Young Adults and Its Association with Cardiovascular Health Metrics in the Progression to Diabetes.
    J Clin Endocrinol Metab. 2022 Apr 21. pii: 6572042. doi: 10.1210.
    PubMed     Abstract available
    
    
    
13. DENG X, Zhang C, Wang P, Wei W, et al
    Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes.
    J Clin Endocrinol Metab. 2022 Apr 9. pii: 6565990. doi: 10.1210.
    PubMed     Abstract available
    
    
    March 2022
14. DAM V, Onland-Moret NC, Burgess S, Chirlaque MD, et al
    Genetically determined reproductive aging and coronary heart disease: a bidirectional two-sample Mendelian Randomization.
    J Clin Endocrinol Metab. 2022 Mar 20. pii: 6550950. doi: 10.1210.
    PubMed     Abstract available
    
    
    
15. NASR A, Matthews K, Janssen I, Brooks MM, et al
    Associations of abdominal and cardiovascular adipose tissue depots with HDL metrics in midlife women: The SWAN Study.
    J Clin Endocrinol Metab. 2022 Mar 17. pii: 6550277. doi: 10.1210.
    PubMed     Abstract available
    
    
    
16. JIANG W, Song Q, Zhang J, Chen Y, et al
    The Association of Consumption Time for Food With Cardiovascular Disease and All-Cause Mortality Among Diabetic Patients.
    J Clin Endocrinol Metab. 2022 Mar 15. pii: 6546321. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2022
17. CHEN D, Zhang Y, Yidilisi A, Xu Y, et al
    Causal associations between circulating adipokines and cardiovascular disease: A Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Feb 3. pii: 6521299. doi: 10.1210.
    PubMed     Abstract available
    
    
    November 2021
18. YANG J, Zheng Y, Li C, Liu YP, et al
    The impact of subclinical hyperthyroidism on cardiovascular prognosis in patients undergoing PCI.
    J Clin Endocrinol Metab. 2021 Nov 29. pii: 6446179. doi: 10.1210.
    PubMed     Abstract available
    
    
    
19. SRINIVASA S, Thomas TS, Feldpausch MN, Adler GK, et al
    Coronary Vasculature and Myocardial Structure in HIV: Physiologic Insights From the Renin-Angiotensin-Aldosterone System.
    J Clin Endocrinol Metab. 2021;106:3398-3412.
    PubMed     Abstract available
    
    
    
20. SAATMANN N, Zaharia OP, Strassburger K, Pesta DH, et al
    Physical fitness and cardiovascular risk factors in the novel diabetes subgroups.
    J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423502. doi: 10.1210.
    PubMed     Abstract available
    
    
    
21. ZUO Y, Han X, Tian X, Chen S, et al
    Association of Impaired Fasting Glucose with Cardiovascular Disease in the Absence of Risk Factor.
    J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423498. doi: 10.1210.
    PubMed     Abstract available
    
    
    October 2021
22. HONG S, Park JH, Han K, Lee CB, et al
    Association between Obesity and Cardiovascular Disease in Elderly Patients with Diabetes: A Retrospective Cohort Study.
    J Clin Endocrinol Metab. 2021 Oct 1. pii: 6379050. doi: 10.1210.
    PubMed     Abstract available
    
    
    September 2021
23. LIANG Y, Chen H, Liu Y, Hou X, et al
    Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China.
    J Clin Endocrinol Metab. 2021 Sep 11. pii: 6368725. doi: 10.1210.
    PubMed     Abstract available
    
    
    August 2021
24. WANG J, Wang Z, Guo F, Zhang Y, et al
    Individual and combined cardiometabolic morbidities and the subsequent risk of cardiovascular events in Chinese adults.
    J Clin Endocrinol Metab. 2021 Aug 24. pii: 6357056. doi: 10.1210.
    PubMed     Abstract available
    
    
    
25. ZHENG YY, Wu TT, Yang Y, Hou XG, et al
    Diabetes and outcomes following personalized antiplatelet therapy in coronary artery disease patients who underwent PCI.
    J Clin Endocrinol Metab. 2021 Aug 19. pii: 6354863. doi: 10.1210.
    PubMed     Abstract available
    
    
    
26. LEE EK, Ahn HY, Ku EJ, Yoo WS, et al
    Cardiovascular outcomes in thyroid cancer patients treated with thyroidectomy: A meta-analysis.
    J Clin Endocrinol Metab. 2021 Aug 4. pii: 6339941. doi: 10.1210.
    PubMed     Abstract available
    
    
    
27. JAUHIAINEN R, Vangipurapu J, Laakso A, Kuulasmaa T, et al
    The association of nine amino acids with cardiovascular events in Finnish men in a 12-year follow-up study.
    J Clin Endocrinol Metab. 2021 Aug 4. pii: 6338727. doi: 10.1210.
    PubMed     Abstract available
    
    
    July 2021
28. YU D, Wang Z, Zhang X, Qu B, et al
    Remnant cholesterol and cardiovascular mortality in patients with type 2 diabetes and incident diabetic nephropathy.
    J Clin Endocrinol Metab. 2021 Jul 22. pii: 6325383. doi: 10.1210.
    PubMed     Abstract available
    
    
    
29. ROMERO DG, Yanes Cardozo LL
    Cardiovascular Events in Polycystic Ovary Syndrome: Is the Debate Settled for Good?
    J Clin Endocrinol Metab. 2021 Jul 10. pii: 6318749. doi: 10.1210.
    PubMed    
    
    
    
30. ARIBAS E, Kavousi M, Laven JSE, Ikram MA, et al
    Aging, cardiovascular risk and SHBG levels in men and women from the general population.
    J Clin Endocrinol Metab. 2021 Jul 1. pii: 6312672. doi: 10.1210.
    PubMed     Abstract available
    
    
    June 2021
31. BERNI TR, Morgan CL, Rees DA
    Women with Polycystic Ovary Syndrome have an increased risk of major cardiovascular events: a population study.
    J Clin Endocrinol Metab. 2021 Jun 1. pii: 6290890. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2021
32. HOU W, Gao J, Jiang W, Wei W, et al
    Meal Timing of Subtypes of Macronutrients Consumption With Cardiovascular Diseases: NHANES, 2003 to 2016.
    J Clin Endocrinol Metab. 2021 May 26. pii: 6279652. doi: 10.1210.
    PubMed     Abstract available
    
    
    
33. 
    Corrigendum to: "Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline".
    J Clin Endocrinol Metab. 2021 May 8. pii: 6272552. doi: 10.1210.
    PubMed    
    
    
    April 2021
34. SHAO S, Zhou K, Liu X, Liu L, et al
    Predictive value of serum lipid for intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease.
    J Clin Endocrinol Metab. 2021 Apr 10. pii: 6219846. doi: 10.1210.
    PubMed     Abstract available
    
    
    March 2021
35. LANGDAHL BL, Hofbauer LC, Forfar JC
    Cardiovascular Safety and Sclerostin Inhibition - a mini-review.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6182322. doi: 10.1210.
    PubMed     Abstract available
    
    
    
36. BELLO-CHAVOLLA OY, Antonio-Villa NE, Fernandez-Chirino L, Vargas-Vazquez A, et al
    Letter to the Editor from Omar Yaxmehen Bello-Chavolla: "Are the Different Diabetes Subgroups Correlated With All-Cause, Cancer related, and Cardiovascular-related Mortality?"
    J Clin Endocrinol Metab. 2021 Mar 17. pii: 6174421. doi: 10.1210.
    PubMed    
    
    
    
37. LI PF, Chen WL
    Response Letter to the Editor from Bello-Chavolla OY: "Are the Different Diabetes Subgroups Correlated With All-Cause, Cancer related, and Cardiovascular-related Mortality?"
    J Clin Endocrinol Metab. 2021 Mar 17. pii: 6174426. doi: 10.1210.
    PubMed    
    
    
    
38. TORKY A, Sinaii N, Jha S, Desai J, et al
    Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156969. doi: 10.1210.
    PubMed     Abstract available
    
    
    
39. YEN CL, Fan PC, Lin MS, Lee CC, et al
    Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk among Patients with Advanced CKD.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156972. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2021
40. NGAOSUWAN K, Johnston DG, Godsland IF, Cox J, et al
    Cardiovascular disease in patients with primary and secondary adrenal insufficiency and the role of comorbidities.
    J Clin Endocrinol Metab. 2021 Feb 15. pii: 6135110. doi: 10.1210.
    PubMed     Abstract available
    
    
    January 2021
41. SHUFELT CL, Manson JE
    Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery.
    J Clin Endocrinol Metab. 2021 Jan 28. pii: 6121688. doi: 10.1210.
    PubMed     Abstract available
    
    
    November 2020
42. KAHALI B, Chen Y, Feitosa MF, Bielak LF, et al
    A noncoding variant near PPP1R3B promotes liver glycogen storage and MetS, but protects against myocardial infarction.
    J Clin Endocrinol Metab. 2020 Nov 24. pii: 5999530. doi: 10.1210.
    PubMed     Abstract available
    
    
    
43. LIU M, Zhang Z, Zhou C, He P, et al
    Relationship of weight change patterns from young to middle adulthood with incident cardiovascular diseases.
    J Clin Endocrinol Metab. 2020 Nov 12. pii: 5979521. doi: 10.1210.
    PubMed     Abstract available
    
    
    
44. YLLI D, Wartofsky L, Burman KD
    Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders.
    J Clin Endocrinol Metab. 2020 Nov 7. pii: 5959942. doi: 10.1210.
    PubMed     Abstract available
    
    
    October 2020
45. COUPER JJ, Jones TW, Chee M, Barrett HL, et al
    Determinants of cardiovascular risk in 7,000 youth with type 1 diabetes in the Australasian Diabetes Data Network.
    J Clin Endocrinol Metab. 2020 Oct 30. pii: 5943231. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2020
46. MAROULI E, Kus A, Del Greco M F, Chaker L, et al
    Thyroid function affects the risk of stroke via atrial fibrillation: a Mendelian Randomization study.
    J Clin Endocrinol Metab. 2020 May 6. pii: 5831244. doi: 10.1210.
    PubMed     Abstract available
    
    
    April 2020
47. CALDER GL, Ward GM, Sachithanandan N, MacIsaac RJ, et al
    Insulin Autoimmune Syndrome: A Case of Clopidogrel-induced Autoimmune Hypoglycemia.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    February 2020
48. CAO M, Cui B
    Negative Effects of Age at Menarche on Risk of Cardiometabolic Diseases in Adulthood: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: